A multi-institution phase I trial of ruxolitinib in chronic myelomonocytic leukemia (CMML)

Eric Padron; Amy Elizabeth Dezern; Kris Vaddi; Peggy A Scherle; Qing Zhang; Yan Ma; Maria Balasis; Sara Tinsley; Hanadi Ramadan; Casandra Zimmerman; David P. Steensma; Gail J. Roboz; Jeffrey E. Lancet; Alan F. List; Mikkael A. Sekeres; Rami S. Komrokji

doi:10.1200/jco.2015.33.15_suppl.7021

Back

A multi-institution phase I trial of ruxolitinib in chronic myelomonocytic leukemia (CMML)

Journal article

Peer reviewed

A multi-institution phase I trial of ruxolitinib in chronic myelomonocytic leukemia (CMML)

Eric Padron, Amy Elizabeth Dezern, Kris Vaddi, Peggy A Scherle, Qing Zhang, Yan Ma, Maria Balasis, Sara Tinsley, Hanadi Ramadan, Casandra Zimmerman, …

Journal of clinical oncology, Vol.33(15_suppl), pp.7021-7021

2015-05-20

DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.7021

Metrics

2 Record Views

Details

Title: A multi-institution phase I trial of ruxolitinib in chronic myelomonocytic leukemia (CMML)
Creators: Eric Padron - Moffitt Cancer Center
Amy Elizabeth Dezern - Sidney Kimmel Comprehensive Cancer Center
Kris Vaddi - Incyte
Peggy A Scherle - Incyte
Qing Zhang - Moffitt Cancer Center
Yan Ma - Moffitt Cancer Center
Maria Balasis - Moffitt Cancer Center
Sara Tinsley - Moffitt Cancer Center
Hanadi Ramadan - Moffitt Cancer Center
Casandra Zimmerman - Cleveland Clinic
David P. Steensma - Dana-Farber Cancer Institute
Gail J. Roboz - NewYork–Presbyterian Hospital
Jeffrey E. Lancet - Moffitt Cancer Center
Alan F. List - Moffitt Cancer Center
Mikkael A. Sekeres - Cleveland Clinic
Rami S. Komrokji - Moffitt Cancer Center
Publication Details: Journal of clinical oncology, Vol.33(15_suppl), pp.7021-7021
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757836102976